Maynard Um
-
-
-
-
-
-
-
Precigen gets seven-year US exclusivity for rare disease drug PAPZIMEOS
-
-
-
-
-
-
-
Precigen Inc. (PGEN) PT Raised to $9 at Citizens- PAPZIMEOS Can Dominate RRP Market
-
-
-
-
-
-
-
Precigen secures up to $125 million credit facility with Pharmakon
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Precigen Inc. (PGEN)
-
-
-
-
-
-
-
Increasing unusual call option volume: INFY CSGP BMBL GLBE WIX DB PGEN
-
-
-
-
-
-
-
Precigen Inc. (PGEN) Prices 35.29M Share Offering at $0.85/sh
-
-
-
452,990 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

